]>
IRCT20230128057255N1 IRCT 2023-06-27 Iran University of Medical Sciences effectiveness of integrated transdiagnostic therapy Investigating the pattern of transdiagnostic related to emotion regulation of adolescents with high-risk behavior and effectiveness of integrated transdiagnostic therapy on reduction of their anxiety, depression, and emotional dysregulation 2023-08-03 anticipated 60 Complete https://irct.ir/trial/68397 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: None, Randomization description: The randomization method is a simple randomization method. The unit of randomization is individual. Using the table of random numbers, patients are randomly divided into two groups: The experimental group and the control group. Even numbers are considered for the experimental group and odd numbers are for the control group. Random allocation is done by the researcher and the clinical caregiver and data analyzer are not aware of the allocation of patients, Blinding description: Treatment allocation was concealed from the therapist and the data analyzer who specified patients by using random table, and opaque, and sealed envelopes. participants pick up envelopes inside the box randomly which are in an unspecified wrapper. They are aware of which experimental group they were assigned to. N/A Condition 1: Anxiety. Condition 2: Depression. Condition 3: Emotional dysregulation. Intervention 1: Control group: Patients do not receive any intervention during the 12 weeks. Intervention 2: Intervention group: Patients receive 1 30-minute tranactional training session every week for 12 weeks. Yes - There is a plan to make this available What will be shared: Only part of the data, such as information related to main outcome or like that , can be share. When: Start of access, 6 months after publishing the results To whom: Only people working in academic institutions could apply. Conditions: People who are conducting clinical trials in this field could apply. Where to obtain: By referring to the electronic address: s.hasanvandi@alzahra.ac.ir How to obtain: The applicant can receive information by registering the exact personal details. Comments:
public Meysam Nikdanesh
No 65, Block 3, Ekbatan, Tehran
Tehran Iran (Islamic Republic of) 1446789545 +98 919 484 9599 meysamnikdanesh@gmail.com Iran University of Medical Sciences scientific Meysam Nikdanesh
No 65, Block 3, Ekbatan, Tehran
Tehran Iran (Islamic Republic of) 1446789768 +98 919 484 9599 meysamnikdanesh@gmail.com Iran University of Medical Sciences Iran (Islamic Republic of) Diagnosis of anxiety based on Diagnostic and Statistical Manual of Mental Disorders (DSM) No use of Vitamin D3 before the study Lack of any psychotherapy during last 2 months 12 years 17 years Both seizure Systolic blood pressure over 12 Drug allergy F41.9 F32 F93 Anxiety disorder, unspecified Depressive episode Emotional disorders with onset specific to childhood Behavior Treatment - Other Control group: Patients do not receive any intervention during the 12 weeks. Intervention group: Patients receive 1 30-minute tranactional training session every week for 12 weeks. Anxiety symptoms. Timepoint: Assessment of anxiety at the beginning of the study (before the intervention), weeks 4, 8 and 12. Method of measurement: Beck Anxiety Inventory. Iran University of Medical Sciences Approved 2022-01-26 Ethics committee of Iran university of medical sciences Office of Vice President for International Affairs, Iran University of Medical Sciences (IUMS), Shahid Hemmat Highway, Tehran Tehran Tehran Iran (Islamic Republic of)